Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec;11(4):1713-7.
doi: 10.1208/s12249-010-9551-4. Epub 2010 Nov 30.

Solubility of pioglitazone hydrochloride in binary and ternary mixtures of water, propylene glycol, and polyethylene glycols 200, 400, and 600 at 298.2 k

Abolghasem Jouyban  1 , Shahla Soltanpour
Affiliations

Solubility of pioglitazone hydrochloride in binary and ternary mixtures of water, propylene glycol, and polyethylene glycols 200, 400, and 600 at 298.2 k

Abolghasem Jouyban et al. AAPS PharmSciTech. 2010 Dec.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Effect of excess solid on the aqueous solubility of PGZ-HCl
See this image and copyright information in PMC

References

    1. Bradbury J. Explanation found for “glitazone paradox”. Lancet. 2002;360:1003. doi: 10.1016/S0140-6736(02)11125-1. - DOI
    1. Prashantha Kumar BR, Nanjan MJ. Novel glitazones: Design, synthesise, glucose uptake and structure-activity relationships. Bioorg Med Chem Lett. 2010;20:1953–6. doi: 10.1016/j.bmcl.2010.01.125. - DOI - PubMed
    1. Cohen A, Rabbani A, Shah N, Caleb Alexander G. Changes in glitazone use among office-based physicians in the US, 2003–2009. Diabetes Care. 2010;33:823–5. doi: 10.2337/dc09-1834. - DOI - PMC - PubMed
    1. Nakatsuji H, Kishida K, Shimomura I. Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes. Atherosclerosis. 2010;212:243–5. doi: 10.1016/j.atherosclerosis.2010.05.025. - DOI - PubMed
    1. Sakurai H, Iwamoto T. Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging 2009; doi:10.1016/j.neurobiolaging.2009.10.009. - PubMed

Publication types